TSX:PRN (Canada)  
Profound Medical Corp logo

Profound Medical Corp

C$ 5.55 (+1.46%) Sep 28
P/E:
At Loss
P/B:
1.33
Market Cap:
C$ 115.72M ($ 85.00M)
Enterprise V:
C$ 45.09M ($ 33.12M)
Volume:
7.49K
Avg Vol (2M):
17.51K
Also Trade In:
Volume:
7.49K
Market Cap C$:
115.72M
Market Cap $:
85.00M
PE Ratio:
At Loss
Avg Vol (2-Month):
17.51K
Enterprise Value C$:
45.09M
Enterprise Value $:
33.12M
PB Ratio:
1.33
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Name Current Vs Industry Vs History
Cash-To-Debt 43.21
Equity-to-Asset 0.93
Debt-to-Equity 0.02
Debt-to-EBITDA -0.04
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.96
Distress
Grey
Safe
Beneish M-Score -3.35
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 22.77
9-Day RSI 22.4
14-Day RSI 25.12
6-1 Month Momentum % -22.35
12-1 Month Momentum % -53.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 19.64
Quick Ratio 17.23
Cash Ratio 16.04
Days Inventory 669.87
Days Sales Outstanding 218.83
Days Payable 225.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.3

Financials (Next Earnings Date:2022-11-04 Est.)

TSX:PRN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 8.812
EPS (TTM) (C$) -1.859
Beta 1.32
Volatility % 51.06
14-Day RSI 25.12
14-Day ATR (C$) 0.458846
20-Day SMA (C$) 7.03325
12-1 Month Momentum % -53.52
52-Week Range (C$) 5.29 - 19.84
Shares Outstanding (Mil) 20.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Profound Medical Corp Filings

Document Form Filing Date
No Filing Data

Profound Medical Corp Analysis

Share your research